Plasma OPN levels were significantly higher in patients who reported at least one post-COVID-19 symptom compared with asymptomatic ones, either when the entire study population was considered (Figure 1A) or when only samples obtained during late visits were analyzed (Figure 1B). The gene discussed is SPP1; the disease is COVID-19.